Form D · Pharmaceuticals

Allinaire Therapeutics, LLC

Cleveland, OH · CIK 0001676987

Offering snapshot reported Dec 11, 2018 · SEC filing

Reported sold
$1.57M
Offering amount: $5M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 12, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$786K$1.57MDec 16, 2016: $950,000.00Dec 16, 2016Dec 12, 2017: $1,200,000.00Dec 12, 2017Dec 11, 2018: $1,571,800.00Dec 11, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$950,000 → $1,571,800
  • Reported investors4 → 8

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 11, 2018Amendment$1,571,800$621,800vs Dec 16, 20168SEC filing
Dec 12, 2017Amendment$1,200,000$250,000vs Dec 16, 20167SEC filing
Dec 16, 2016Initial$950,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-276461

Source: Form D, filed Dec 11, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Baiju Shah Director, Executive
Brian Stemme Director
Ted Torphy Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
20600 Chagrin Blvd. Suite 210
Cleveland, OH, 44122